Prediction: Eli Lilly Stock Could Surge 45% This Year

MrDecoder · 2026-02-20T07:21:25+00:00

Eli Lilly showcased impressive 45% revenue growth and projects $83 billion in sales by 2026. With strong obesity drug prospects and growth drivers, analysts believe significant upside remains for long-term investors.

MrDecoder

2026-02-20 07:21:25

Abstract generation in progress

Eli Lilly (LLY +0.23%) just delivered 45% revenue growth and guided toward $83 billion in 2026 sales. With blockbuster obesity drugs, multiple growth catalysts, and analysts targeting $1,500, this healthcare powerhouse may still have substantial upside ahead for long-term investors.

Stock prices used were the market prices of Feb. 13, 2026. The video was published on Feb. 17, 2026.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes